

Next goal: 5
Presenting Sponsor
+ Become the presenting sponsorPresenting Sponsor
+ Become the presenting sponsorPresenting Sponsor
+ Become the presenting sponsorSilver Sponsor
+ Become a sponsorSilver Sponsor
+ Become a sponsorSilver Sponsor
+ Become a sponsorSilver Sponsor
+ Become a sponsorSilver Sponsor
+ Become a sponsorNomination created on January 19, 2026
Next goal: 5
Champion Hub
Every way to move this nomination, in one place.

Michael Saylor on The Joe Rogan Experience335 votes
Anand Mahindra on WTF is with Nikhil Kamath98 votes
Vaclav Smil on Dwarkesh Podcast27 votes
Leemon Baird on Lex Fridman Podcast33 votes
Elon Musk on Relentless178 votes
Richard Heart on The Joe Rogan Experience1,195 votes
DataRepublican (small r) on PBD Podcast65 votes
Karl Friston on Dwarkesh Podcast22 votes
Alexandria Ocasio-Cortez on This Past Weekend w/ Theo Von7 votes
Robert F. Kennedy Jr on Huberman Lab3 votes
Lily Tang Williams on The Joe Rogan Experience894 votes
Alexandria Ocasio-Cortez on The Tucker Carlson Show7 votes
Nicki Minaj on Real Talk with Zuby6 votes
ZUBY: on Chrissie Mayr Podcast1 vote
Greta Thunberg on Impaulsive with Logan Paul2 votes
TimothΓ©e Chalamet on Armchair Expert with Dax Shepard2 votes
Professor @Harvard researching why we age & how to reverse it. Author & host of Lifespan. Mission: Extend healthy life for all. Views are entirely his own πβοΈ
Dive into the cutting-edge worlds of technology and science with Dwarkesh Patel's meticulously researched interviews that bring together brilliant minds to unpack revolutionary ideas in AI, biotech, and beyond. Each episode delivers profound, thought-provoking conversations that challenge conventional wisdom and illuminate the paths shaping humanity's future.
David Sinclair matters today because the cellular reprogramming work he helped pioneer is finally moving into humans, with Life Biosciences planning first-in-human trials of its OSK-based ER-100 for two optic neuropathies in early 2026. If those trials show even partial vision restoration, it could reset the debate over whether aging processes are tractable in living patients right now, not in some distant future.
At the same time, the FDA reversed course in late 2025 to allow NMN back on the U.S. supplement market, a compound Sinclair popularized, which puts his ideas about NAD metabolism and consumer longevity products back in the spotlight. Pair that momentum with mainstream coverage of reprogrammingβs clinical push and you have a rare window where policy, biotech, and public interest are aligning.
There is controversy to press him on, including criticism about past overhype and conflicts of interest, which makes a rigorous, well-researched conversation on Dwarkeshβs show especially timely and valuable. By our search, he has not appeared on the Dwarkesh Podcast before, so this would be a first encounter for that audience with the fieldβs most polarizing advocate.
If you want this pivotal conversation to happen while trials begin and rules shift, back this nomination today.
No voices yet. Submit a tweet, video, or post to be the first.
Champion Hub
2 people want this. Add your vote.
0 of 6 done
Record a short video telling everyone why this dialogue should happen. Your clip gets featured right here.
What's a Key Catalyst?
A Key Catalyst is someone whose voice carries trust. By sharing or supporting this nomination, they help ensure the right conversations actually happen.
Rally support from known voices who can help accelerate this nomination

Biogerontologist
Why Their Voice Would Be Valuable
Kaeberlein provides evidence-based perspectives on aging biology and evaluates claims made by researchers like Sinclair.

Chief Science Officer of LEVβ¦
Why Their Voice Would Be Valuable
He has spent decades arguing that aging should be cured as an engineering problem, aligning with the techno-optimist tone of the podcast.

Neuroscientist and podcast host
Why Their Voice Would Be Valuable
Huberman frequently explores protocols and supplements impacting human performance, overlapping with Sinclair's audience.

Tech entrepreneur and biotech founder
Why Their Voice Would Be Valuable
Hodak operates at the intersection of frontier science and frequently comments on futuristic biotech and anti-aging.

Economist and author
Why Their Voice Would Be Valuable
Cowen monitors macro trends in technology and the economic implications of radical life extension.
What are the best superfoods to eat to slow aging of our cells?
Suggested
How should the longevity community handle the reproducibility crisis in small-animal studies?
Many exciting longevity findings in rodents fail to replicate or are confounded by strain, diet, and husbandry. What changes need to happen?
Can epigenetic reprogramming become a real therapy for human aging in the next decade?
Given the success in mice with Yamanaka factors and the technical hurdles of delivery and partial reprogramming, what is your honest timeline?
Why Their Voice Would Be Valuable
As a prominent longevity physician and host of The Drive, Attia closely tracks the geroscience and clinical data discussed by Sinclair.